Aspartate amino transferase (AST or SGOT) and alanine amino transferase (ALT or SGPT) ? .  institutional ULN.
Aspartate amino transferase (AST) or alanine amino transferase (ALT) > . times the upper limit of normal (ULN).
Alanine amino transferase (ALT) and aspartate aminotransferase (AST) =< . X ULN (may not have abnormalities in both bilirubin and transaminases)
Obtained =<  days prior to registration: Alanine amino transferase (ALT) < . X ULN, with normal bilirubin; NOTE: Concomitant elevations in bilirubin and ALT above . x ULN (upper limit of normal) is not permitted
Within  weeks prior to study registration: \r\nAlanine aminotransferase (ALT) and aspartate amino-transferase (AST) =< . x ULN (=<  x ULN for subjects with liver involvement of their cancer) within  weeks prior to study registration
Aspartate amino transferase (AST) or Alanine amino transferase (ALT) > times ULN in patient without liver metastasis or liver cirrhosis
Alanine aminotransferase (ALT) and aspartate amino-transferase (AST) =< . x ULN (=<  x ULN for subjects with liver involvement of their cancer or stent placement)
Aspartate amino-transferase (AST) =< . x ULN (=<  x ULN for subjects with liver involvement of their cancer)
Alanine aminotransferase (ALT) and aspartate amino-transferase (AST) =< . x ULN (=<  x ULN for subjects with liver involvement of their cancer)
Aspartate amino transferase (AST or serum glutamic oxaloacetic transaminase [SGOT]) and alanine amino transferase (ALT or serum glutamate pyruvate transaminase [SGPT]) =< . x institutional ULN
Aspartate amino transferase (AST) or alanine amino transferase (ALT) =< three times the upper limit of (institutional/central) normal (ULN) (if related to liver metastases =< five times ULN)
Alanine aminotransferase (ALT) and aspartate amino-transferase (AST) =< . x ULN (=<  x ULN for subjects with liver involvement of their cancer)
Aspartate amino transferase (AST) or alanine amino transferase (ALT) >= . times the upper limit of normal (if related to liver metastases >= five times the upper limit of normal)
Alanine aminotransferase (ALT) and aspartate amino-transferase (AST) ? . x ULN
Alanine aminotransferase (ALT) and aspartate amino-transferase (AST) =< . x ULN (=<  x ULN for subjects with liver involvement of their cancer) (obtained =<  days prior to randomization)
Alanine amino transferase (ALT) and aspartate aminotransferase (AST) =< . x ULN (tested within  days prior to registration)\r\n* Concomitant elevations in bilirubin and AST/ALT above . x ULN (upper limit of normal) are not permitted
Alanine amino transferase (ALT) and aspartate aminotransferase (AST) < . x ULN (upper limit of normal); concomitant elevations in AST/ALT above . x ULN are not permitted
Serum aspartate aminotransferase and alanine amino-transferase of at least  times the upper limit of normal
Aspartate amino transferase (AST) or alanine amino transferase (ALT) greater than . times the upper limit of normal (ULN), or AST or ALT greater than  times the ULN for those with Gilbert syndrome.
Aspartate amino transferase (AST) or alanine amino transferase (ALT) >= three () times the upper limit of normal
Alanine amino transferase (ALT) or aspartate amino transferase (AST) greater than . times the ULRR if no demonstrable liver metastases or greater than  times the ULRR in the presence of liver metastases.
Alanine aminotransferase (ALT) and aspartate amino-transferase (AST) =< . x ULN
Alanine aminotransferase (ALT) and aspartate amino-transferase (AST) =< . x ULN (=<  x ULN for subjects with liver involvement of their cancer)
Total bilirubin =< . X ULN (evaluated within  days of randomization); concomitant elevations in bilirubin and aspartate amino transferase (AST)/alanine aminotransferase (ALT) above . x ULN are not permitted